Blockchain Registration Transaction Record

Propranolol Shows Potential in Reducing Ischemic Stroke Risk in Women with Migraines

Propranolol, a medication used for high blood pressure and migraines, may lower ischemic stroke risk in women with migraines. The study presented at the American Stroke Association’s International Stroke Conference 2025 suggests a stronger protective effect of propranolol for ischemic stroke in women, emphasizing the importance of preventive treatments for migraine-related stroke risk.

This news highlights the potential benefits of propranolol in reducing stroke risk for women with migraines, especially those without aura. Understanding the effectiveness of preventive treatments like propranolol is crucial for women's health, as migraines are more common in women and are associated with an increased risk of stroke. This study underscores the importance of personalized care and access to preventive interventions for under-resourced individuals to reduce health disparities.